On February 17, 2025, GSK plc granted conditional share awards to its executive team under the 2017 Performance Share Plan, with award prices at £14.35 per share for a total of 1,787,608 shares. This plan rewards performance over a three-year period ending December 31, 2027, including specific vesting conditions.